Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AMGN vs GSK✓SelectedUSD · GSKAMGN vs GSK performance historyLatest closeAs of-0.30%11/13
Stock and ETF performance explorer

AMGN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.0%
GSK return
+65.8%
Excess return
+25.2%
Maximum drawdown
-22.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%+0.5%-0.8%-0.6%
7D+1.1%+1.1%0.0%+0.5%
30D+9.3%+6.3%+2.9%+5.7%
3M+12.1%+1.8%+10.3%+11.0%
6M+40.3%+1.7%+38.6%+38.8%
YTD+45.2%+6.5%+38.6%+40.8%
1Y+42.4%+9.5%+32.9%+36.5%
3Y+91.0%+65.3%+25.7%+53.1%
All+91.0%+65.8%+25.2%+53.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling